Carbamazepine recalls

Carbamazepine products have been recalled 4 times, most recently on 26 Aug 2026. The recalling company is usually Torrent Pharma. The most common reason is potency & assay.

Total recalls4since 2020

Last 12 months1reported

Class I00% of total

Ongoing2latest 26 Aug 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 1 0Nov 0 0 0Feb 0 0 0May 0 0 1Aug 0 0

Severity split

Class I 0 0%Class II 4 100%Class III 0 0%

Why carbamazepine is recalled

Potency & Assay375%
Manufacturing (CGMP) Deviations125%

Companies

Product types

Seizure Medication4100%

By year

2026125%
2025125%
2022125%
2020125%

Ongoing carbamazepine recalls

2 active

Reported	Class	Recall	Company	Reason	Where
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalledCarbamazepine	Golden State Medical Supply	Manufacturing (CGMP) Deviations	Nationwide
8 Oct 2025Drug	CLASS II	Carbamazepine Extended-Release Tablets recalledCarbamazepine	Amerisource Health Services	Potency & Assay	Nationwide

All carbamazepine recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
26 Aug 2026Drug	CLASS II	Carbamazepine Tablets, USP, 200mg recalledCarbamazepine	Golden State Medical Supply	Manufacturing (CGMP) Deviations	Nationwide
8 Oct 2025Drug	CLASS II	Carbamazepine Extended-Release Tablets recalledCarbamazepine	Amerisource Health Services	Potency & Assay	Nationwide
19 Jan 2022Drug	CLASS II	Carbamazepine Tablets, USP 200 mg recalled by Torrent PharmaCarbamazepine	Torrent Pharma	Potency & Assay	Nationwide
10 Jun 2020Drug	CLASS II	Carbamazepine Tablets, USP 200 mg recalled by Torrent PharmaCarbamazepine	Torrent Pharma	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.